查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1867137

冠狀動脈疾病市場按產品類型、手術類型和最終用戶分類 - 全球預測 2025-2032

Coronary Artery Disease Market by Product Type, Procedure Type, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，冠狀動脈疾病市場將成長至 197.8 億美元，複合年成長率為 5.86%。

關鍵市場統計數據
基準年 2024 125.3億美元
預計年份：2025年 132.7億美元
預測年份 2032 197.8億美元
複合年成長率 (%) 5.86%

本書對冠狀動脈疾病的發展趨勢、不斷演變的臨床實踐以及塑造現代患者照護的醫療設備創新進行了簡明扼要、權威的概述。

冠狀動脈疾病仍然是心血管醫學領域最嚴峻的挑戰之一，其發展受到人口統計和生活方式因素以及診斷和治療技術進步的複雜影響。近年來，臨床醫生和醫療設備製造商積極應對不斷變化的環境，影像技術的進步、新型支架材料的出現以及先進治療技術的進步正在重塑患者的診療路徑和臨床結果。尤其重要的是，精準醫療的日益普及促使心臟病團隊將血管內影像和生理評估相結合，以實現個人化的治療決策並減少手術相關併發症。

了解這些趨勢對於醫療保健領域所有相關人員都至關重要，因為技術創新、不斷變化的法規環境以及醫療實踐的轉型共同影響產品開發的優先事項和投資決策。因此，產業相關人員必須將臨床證據的生成與實際治療路徑的最佳化相結合，以展現價值、推動報銷談判並加速產品應用。本導言旨在為深入探討正在進行的變革、關稅的影響、市場區隔的細微差別、區域因素、企業策略以及可操作的建議奠定基礎。

識別從根本上重塑冠狀動脈介入治療實踐和器械優先順序的臨床、技術和商業性轉折點。

冠狀動脈疾病的治療模式在臨床、技術和商業性層面都經歷了變革性的變化，改變了醫療服務的提供方式和產品評估框架。在臨床上，決策方式從單純依賴血管造影術轉向綜合血管內影像和生理評估，降低了不確定性，提高了介入標靶選擇的準確性。同時，提供高解析度血管內超音波（IVUS）和光學同調斷層掃描（OCT）成像的系統變得日益重要。在技​​術上，生物可吸收支架和新一代藥物釋放型平台的出現，反映了人們不斷追求機械性能與長期血管癒合之間平衡的努力。此外，導管導引線和導管設計的不斷改進也提高了輸送性能和手術安全性。

在商業性，不斷演變的報銷機制和對基於價值的醫療結果日益成長的關注，正促使採購重點轉向能夠減少併發症和縮短手術時間的設備。此外，門診手術路徑的興起和混合醫療模式的成熟，也催生了對小型化、易用型設備和整合影像解決方案的新需求。總而言之，這些變化凸顯了當前市場環境的關鍵在於：臨床證據、與醫院系統的互通性以及以患者為中心的顯著療效，這些因素將決定產品的競爭地位和市場接受度。

評估2025年美國關稅如何推動冠狀動脈介入器材生態系統的供應鏈重組、採購多元化和策略協議的達成。

2025年美國關稅政策的實施，為冠狀動脈介入技術的供應鏈規劃與定價策略帶來了新的變數。製造商和經銷商紛紛調整因應措施，重新評估籌資策略，加快供應商多元化，並修訂庫存管理政策，以保障利潤率和服務連續性。許多公司將部分生產業務遷至更靠近終端市場的地方，或優先與區域性契約製造製造商合作，以降低關稅風險，並為醫院採購領域維持價格競爭力。

同時，採購部門和醫療系統也越來越關注醫療總成本和醫療設備生命週期經濟效益，迫使供應商提供全面的服務合約和臨床支援方案，以抵銷短期價格壓力。與監管機構的互動也變得愈發重要，以便在不影響產品註冊的情況下證明零件來源並認證替代供應商。總而言之，這些調整反映了整個行業向更強大的供應鏈韌性、透明的成本結構和協作式合約模式的轉變，旨在確保患者能夠獲得先進的介入治療工具，同時應對貿易政策變化帶來的營運影響。

深度細分分析揭示了產品類型、流程路徑和最終用戶環境如何驅動差異化的採用模式和策略重點。

細分市場層面的趨勢揭示了產品、手術和終端使用者層面不同的應用模式和投資需求，這主要受臨床效用和營運限制的驅動。就產品類型而言，球囊和導管導引線仍然是病變預備和複雜解剖結構導航的基礎工具。同時，由於抗增殖塗層和支架設計的改進，冠狀動脈支架（包括裸金屬支架、生物可吸收支架和藥物釋放型支架）持續受到關注，這些改進旨在降低血管再阻塞和長期植入負擔。在風險較高的解剖結構中，栓塞保護裝置正被擴大用於減少遠端栓塞。此外，包括血管內超音波和光學同調斷層掃描在內的成像系統對於規劃和最佳化支架植入至關重要，尤其是在複雜病變和分叉病變中。

從手術類型角度來看，冠狀動脈繞道手術手術仍是治療多支血管病變和解剖結構複雜疾病的關鍵手段，根據患者風險狀況和外科醫師經驗選擇非體外循環或體外循環手術方式。同時，經經皮冠狀動脈介入治療（PCI），包括球囊擴張成形術和支架置放術，憑藉先進的器械平台和輔助影像引導技術，其臨床應用範圍不斷擴大。最後，終端用戶細分凸顯了醫療服務模式的改變。隨著微創、低風險介入治療逐漸從傳統的住院醫療機構轉移，門診手術中心正在蓬勃發展。心臟病診所作為診斷和隨訪中心的作用也在不斷增強，而醫院仍然是嚴重病例和混合手術的重要中心。整合這些細分觀點，有助於更清楚地了解創新投資和商業性重點將在哪些方面產生最大的臨床和營運效益。

推動市場進入、普及和投資重點的區域和基礎設施趨勢（美洲、歐洲、中東和非洲、亞太地區）

區域趨勢反映了人口壓力、醫療基礎設施成熟度和政策促進因素交織而成的複雜網路，這些因素共同塑造了臨床實踐和採購行為。在美洲，成熟的介入性心臟病學網路和完善的報銷體系支持了先進影像系統和第二代藥物釋放型支架的快速普及，同時醫療系統也日益重視綜合支付模式和手術效率。在歐洲、中東和非洲，各國醫療體系的差異導致先進技術的應用水平不一，但一條通用的發展路徑清晰可見：在區域培訓舉措和公私合營的支持下，構建血管內影像能力並擴大微創治療方案的覆蓋範圍。在亞太地區，人口結構變化和心血管疾病盛行率的上升正推動著對導管室基礎設施的大量投資，從而提升了本地製造和技術轉移在控制成本和拓展市場方面的作用。

在全部區域，監管協調工作、臨床醫師教育計畫和基礎建設資金籌措機制正成為推動技術應用的重要因素。報銷機制和醫院採購方式的差異持續影響供應商的合作策略，使得跨國合作開展臨床證據產生工作對那些尋求在更廣泛區域內站穩腳跟的公司而言變得日益重要。

技術深度、臨床證據策略和服務導向交付如何定義領先和新興冠狀動脈器械公司的競爭優勢

冠狀動脈介入器材領域的競爭優勢依賴於技術深度、臨床證據累積以及支持終端用戶營運目標的綜合服務。主要企業致力於將互補的成像技術、支架和輸送技術整合到其產品組合中，以實現一致的臨床工作流程。這些企業大力投資研究者主導的臨床試驗和上市後註冊研究，以證明手術獲益和長期安全性，同時也開發外科醫生培訓項目，以最佳化器械使用和治療效果。策略聯盟和選擇性收購加速了高解析度影像技術和新型支架材料等細分技術的普及，使現有企業能夠為醫院系統和門診中心提供差異化的價值提案。

規模較小但極具創新精神的公司正專注於突破性材料、專用輸送機制和基於軟體的影像增強技術，透過專注於臨床合作展示自身實力，並吸引大型醫療設備公司的收購興趣。同時，隨著醫療系統尋求可預測的治療效果和簡化的採購流程，將設備與分析、培訓和流程支援相結合的服務導向模式正日益受到青睞。規模、專業知識和服務整合方面的競爭將繼續決定哪些公司能夠獲得臨床認可和醫療機構的採購承諾。

醫療設備製造商和醫療系統可採取的策略重點，以將創新轉化為持續的臨床應用、供應鏈韌性和商業性價值。

產業領導者應採取果斷行動，確保產品開發與臨床工作流程最佳化和買家不斷變化的期望保持一致。首先，應優先發展將影像和生理評估功能整合到支架和支架平台中的開發平臺，以提供端到端的外科解決方案和清晰的價值提案。其次，應投資於產生可靠的真實世界證據和外科醫生培訓項目，以降低新技術應用門檻，增強市場信心。第三，應透過多元化製造地和建立策略供應商關係來增強供應鏈韌性，從而減輕關稅波動的影響，並確保不受地理限制的產品穩定供應。

此外，為了滿足日益成長的對可預測的手術效果和總成本透明度的需求，可以考慮擴展基於服務的商業模式，將設備與臨床支援和結果分析相結合。最後，儘早與區域監管機構和報銷相關人員進行溝通至關重要，這有助於使證據產生與當地的核准要求和採購優先事項保持一致，從而加快市場准入和實施進度。實施這些建議將有助於各機構將創新轉化為永續的臨床和商業性成果。

本報告的分析採用了嚴謹的混合方法研究途徑，結合了臨床醫生訪談、臨床文獻綜述、監管分析和供應鏈評估，以得出檢驗的研究結果。

本報告的分析整合了多方面的證據，以確保其穩健性和對決策者的相關性。主要研究包括對介入性心臟病專家、心臟外科醫生、醫院採購人員和醫療設備業高管進行結構化訪談，以了解臨床實踐、臨床偏好和採購考慮。次要研究包括對同儕審查的臨床文獻、監管申報文件、程序指南和已發布的醫療系統採購政策進行系統性回顧，以了解不斷發展的臨床實踐和醫療設備績效指標的背景。

此分析方法結合了相關人員訪談的定性主題分析和產品功能集、報銷環境以及設備生命週期屬性的比較評估，以識別策略轉折點。供應鏈和關稅影響分析利用貿易數據、製造地資訊和公司揭露資訊來評估脆弱性並制定緩解策略。在整個分析過程中，採用多資訊來源檢驗以提高有效性，並根據臨床應用趨勢、採購行為和競爭策略的觀察模式提出建議。

簡明結論摘要了技術、臨床實踐和供應鏈的融合趨勢，這些趨勢將決定長期應用和價值交付。

摘要，冠狀動脈疾病領域呈現出技術創新融合、臨床實踐不斷演進以及供應鏈日益複雜的特點，這些因素共同影響著產品的開發、應用和商業策略。先進的血管內成像技術和新一代支架技術的興起正在重塑臨床路徑，而實踐的轉變和受價格主導的供應鏈則需要靈活的營運規劃。相關人員，將更有利於把創新轉化為永續的應用，並最終改善患者的治療效果。

展望未來，臨床效用、報銷機制和營運效率之間的相互作用將決定哪些技術能夠廣泛應用，哪些技術只能局限於小眾市場。因此，醫療專業人員、製造商和醫療系統採購方之間的持續合作對於確保醫療設備創新能夠持續帶來可衡量的臨床效益和系統層面的價值至關重要。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧演算法整合到冠狀動脈疾病診斷影像工作流程中
  • 擴大使用可生物分解聚合物塗層的藥物釋放型支架，以降低血管再阻塞率
  • 機器人輔助微創經皮冠狀動脈介入技術的出現
  • 增加對PCSK9抑制劑和小干擾RNA療法在低密度脂蛋白膽固醇管理的投資
  • 擴展我們的遠端心臟診斷平台，用於遠端監測穩定型和急性冠狀動脈疾病（CAD）患者。
  • 生物可吸收支架技術的發展（提供結構支撐，無需長期固定血管）
  • 利用CT血管攝影檢查獲得的血流儲備分數（FFR）進行非侵入性病變評估的應用日益廣泛
  • 穿戴式心臟感測器在連續監測和早期檢測缺血事件方面的進展
  • 向以價值為導向的醫療模式轉型，優先考慮具有成本效益的冠狀動脈疾病（CAD）治療和患者預後。
  • 探索基因療法促進冠狀動脈血運重建的合作臨床試驗

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按產品類型分類的冠狀動脈疾病市場

  • 球囊導管
  • 冠狀動脈支架
    • 裸金屬支架
    • 生物可吸收支架
    • 藥物釋放型支架
  • 栓塞保護裝置
  • 導管導引線
  • 影像系統
    • 血管內超音波
    • 光同調斷層掃瞄

9. 冠狀動脈疾病手術市場

  • 冠狀動脈繞道手術手術
    • 非泵送
    • 泵浦上
  • 經皮冠狀動脈介入治療
    • 球囊血管成形術
    • 支架置入術

第10章：冠狀動脈疾病市場（依最終用戶分類）

  • 門診手術中心
  • 心臟病診所
  • 醫院

11. 冠狀動脈疾病市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章：冠狀動脈疾病市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

13. 各國冠狀動脈疾病市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Medtronic plc
    • Terumo Corporation
    • B. Braun Melsungen AG
    • Johnson & Johnson
    • Becton Dickinson and Company
    • Koninklijke Philips NV
    • Edwards Lifesciences Corporation
    • Siemens Healthineers AG
Product Code: MRR-5D693B46C822

The Coronary Artery Disease Market is projected to grow by USD 19.78 billion at a CAGR of 5.86% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 12.53 billion
Estimated Year [2025] USD 13.27 billion
Forecast Year [2032] USD 19.78 billion
CAGR (%) 5.86%

A concise and authoritative orientation to coronary artery disease dynamics, clinical practice evolution, and device innovation shaping contemporary patient care

Coronary artery disease remains one of the foremost clinical challenges in cardiovascular medicine, driven by complex interactions among population demographics, lifestyle factors, and advances in diagnostic and interventional technologies. Over recent years, clinicians and device manufacturers have navigated a shifting environment in which improved imaging modalities, new scaffold materials, and refined interventional techniques have reshaped patient pathways and clinical outcomes. Importantly, the emphasis on precision care has intensified, with cardiology teams increasingly integrating intravascular imaging and physiologic assessment to personalize treatment decisions and reduce procedure-related complications.

For stakeholders across the care continuum, understanding these developments is essential because technological innovation, regulatory dynamics, and changing care settings collectively influence product development priorities and investment choices. Consequently, industry participants must align clinical evidence generation with real-world pathway optimization to demonstrate value, support reimbursement discussions, and accelerate adoption. This introduction sets the stage for a deeper examination of transformative shifts, tariff impacts, segmentation nuances, regional considerations, company strategies, and actionable recommendations that follow.

Identifying the clinical, technological, and commercial inflection points that have fundamentally reshaped coronary intervention practices and device priorities

The landscape for coronary artery disease has experienced transformative shifts that span clinical, technological, and commercial dimensions, altering how care is delivered and how products are evaluated. Clinically, the transition from angiography-only decision making toward comprehensive intravascular imaging and physiologic assessment has reduced uncertainty and improved lesion selection for intervention, while concurrently elevating the importance of systems that provide high-resolution intravascular ultrasound and optical coherence tomography images. Technologically, the emergence of bioresorbable scaffolds and next-generation drug eluting platforms reflects an ongoing drive to balance mechanical performance with long-term vascular healing, and incremental improvements in guidewire and catheter engineering have enhanced deliverability and procedural safety.

Commercially, evolving reimbursement frameworks and an intensified focus on value-based outcomes have shifted procurement priorities toward devices that can demonstrate reduced complications and shorter procedural times. Moreover, the proliferation of ambulatory procedural pathways and the maturation of hybrid care models have created new demand vectors for compact, user-friendly devices and integrated imaging solutions. Taken together, these shifts underscore a market environment where clinical evidence, interoperability with hospital systems, and demonstrable patient-centric outcomes determine competitive positioning and adoption trajectories.

Assessing how United States tariff actions in 2025 catalyzed supply chain realignment, sourcing diversification, and strategic contracting across the coronary devices ecosystem

The introduction of tariffs by the United States in 2025 introduced a new variable into supply chain planning and pricing strategies for coronary intervention technologies. Manufacturers and distributors responded by reassessing sourcing strategies, accelerating supplier diversification, and re-evaluating inventory philosophies to protect margin and service continuity. In many cases, companies prioritized relocating certain manufacturing steps closer to end markets or partnering with regional contract manufacturers to mitigate tariff exposure and preserve competitive pricing for hospital procurement teams.

Concurrently, procurement departments and health systems increased emphasis on total cost of care and device lifecycle economics, prompting suppliers to offer bundled service agreements and clinical support packages that could offset short-term price pressures. Regulatory interactions also became more prominent as firms sought to justify component origin or qualify alternative suppliers without disrupting product registrations. Collectively, these adaptations reflect an industry pivot toward greater supply chain resilience, transparent cost structures, and collaborative contracting models that aim to maintain patient access to advanced interventional tools while absorbing the operational effects of trade policy shifts.

Deep segmentation analysis revealing how product categories, procedural pathways, and end-user settings drive differentiated adoption patterns and strategic priorities

Segment-level dynamics reveal differentiated adoption patterns and investment needs across product, procedure, and end-user dimensions, each driven by clinical utility and operational constraints. Based on product type, balloons and guidewires remain foundational for lesion preparation and crossing complex anatomy, while coronary stents-spanning bare metal stents, bioresorbable scaffolds, and drug eluting stents-continue to command attention due to improvements in antiproliferative coatings and scaffold designs that aim to reduce restenosis and long-term implant burden. Embolic protection devices are increasingly considered in high-risk anatomies to mitigate distal embolization, and imaging systems, including intravascular ultrasound and optical coherence tomography, are integral to planning and optimizing stent deployment, particularly in complex and bifurcation lesions.

When examined through the lens of procedure type, coronary artery bypass grafting retains a critical role in multivessel and anatomically complex disease, with off pump and on pump techniques selected based on patient risk profiles and surgical expertise. Meanwhile, percutaneous coronary intervention, delivered via balloon angioplasty or stenting, continues to expand its clinical envelope through refined device platforms and adjunctive imaging guidance. Finally, end user segmentation highlights the shifting venue of care: ambulatory surgical centers are growing as minimally invasive and lower-risk interventions migrate out of traditional inpatient settings; cardiology clinics are increasingly serving as hubs for diagnostics and follow-up care; and hospitals remain central for high-acuity cases and hybrid procedures. Integrating these segmentation perspectives enables a clearer understanding of where innovation investment and commercial focus can produce the greatest clinical and operational impact.

Regional dynamics and infrastructure trends across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine access, adoption, and investment priorities

Regional trends reflect a tapestry of demographic pressures, healthcare infrastructure maturity, and policy drivers that shape clinical practice and procurement behavior. In the Americas, established interventional cardiology networks and well-developed reimbursement mechanisms support rapid adoption of advanced imaging systems and second-generation drug eluting stents, while health systems increasingly emphasize bundled payment models and procedural efficiency. In Europe, Middle East & Africa, heterogeneity across national healthcare systems leads to variable uptake of premium technologies; however, there is a common trajectory toward capacity building in intravascular imaging and expanded access to minimally invasive options, supported by regional training initiatives and public-private partnerships. In the Asia-Pacific region, demographic shifts and rising cardiovascular disease prevalence are driving significant investment in cath lab infrastructure, with local manufacturing and technology transfer playing growing roles in cost containment and market expansion.

Across these regions, regulatory harmonization efforts, clinician education programs, and infrastructure financing mechanisms have emerged as key enablers of technology diffusion. Differences in reimbursement design and hospital purchasing practices continue to influence vendor engagement strategies, and cross-border collaboration on clinical evidence generation is increasingly important for companies seeking broad regional traction.

How technological depth, clinical evidence strategies, and service-oriented offerings define competitive advantage among leading and emerging coronary device companies

Competitive positioning in the coronary devices arena hinges on a combination of technological depth, clinical evidence generation, and integrated services that support end-user operational goals. Leading companies have concentrated on expanding portfolios to include complementary imaging, scaffolding, and delivery technologies that enable cohesive clinical workflows. These firms invest heavily in investigator-initiated studies and post-market registries to demonstrate procedural benefits and long-term safety, while also deploying educational programs for operators to optimize device use and outcomes. Strategic partnerships and selective acquisitions have accelerated access to niche technologies, such as high-resolution imaging modalities and novel scaffold materials, enabling incumbent firms to offer differentiated value propositions to hospital systems and ambulatory centers.

Smaller, highly innovative companies often focus on breakthrough materials, specialized delivery mechanisms, or software-enabled imaging enhancements, using focused clinical partnerships to prove performance and create acquisition interest from larger medical device organizations. Meanwhile, service-oriented models that bundle devices with analytics, training, and procedural support are gaining traction as health systems demand predictable outcomes and simplified procurement. This competitive interplay between scale, specialization, and service integration will continue to define which companies capture clinical mindshare and institutional purchasing commitments.

Actionable strategic priorities for device makers and health systems to convert innovation into sustained clinical adoption, supply resilience, and commercial value

Industry leaders should act decisively to align product development with clinical workflow optimization and evolving purchaser expectations. First, prioritize development pipelines that integrate imaging and physiologic assessment capabilities with stent and scaffold platforms to enable end-to-end procedural solutions and clearer value propositions. Second, invest in robust real-world evidence generation and operator training programs that lower adoption barriers and accelerate confidence in new technologies. Third, build supply chain resilience through diversified manufacturing footprints and strategic supplier relationships to mitigate tariff volatility and ensure product availability across regions.

Additionally, consider expanding service-based commercial models that bundle devices with clinical support and outcome analytics to meet the growing demand for predictable procedural performance and total cost visibility. Finally, engage early with regional regulatory and reimbursement stakeholders to align evidence generation with local approval requirements and procurement priorities, thereby smoothing market entry and adoption timelines. Executing on these recommendations will help organizations convert innovation into sustainable clinical and commercial outcomes.

A rigorous mixed-methods research approach blending clinician interviews, clinical literature review, regulatory analysis, and supply chain assessment to derive validated insights

The analysis underpinning this report synthesizes multiple evidence streams to ensure robustness and relevance to decision-makers. Primary research included structured interviews with interventional cardiologists, cardiac surgeons, hospital purchasing leaders, and device industry executives to capture operational realities, clinical preferences, and procurement considerations. Secondary research involved systematic reviews of peer-reviewed clinical literature, regulatory filings, procedural guidelines, and publicly available health system procurement policies to contextualize clinical practice evolution and device performance metrics.

Analytical methods combined qualitative thematic analysis from stakeholder interviews with comparative assessments of product feature sets, reimbursement environments, and device lifecycle attributes to identify strategic inflection points. Supply chain and tariff impact analysis drew on trade data, manufacturing location information, and corporate disclosures to assess vulnerability and mitigation approaches. Throughout, findings were triangulated across sources to enhance validity, and recommendations were derived from observed patterns in clinical adoption, procurement behavior, and competitive maneuvering.

A concise conclusion summarizing convergent trends in technology, clinical practice, and supply chain dynamics that will determine long-term adoption and value delivery

In sum, the coronary artery disease landscape is characterized by converging technological innovation, evolving clinical practice, and supply chain complexity, each of which has implications for product development, adoption, and commercial strategy. The rise of advanced intravascular imaging and next-generation stent technologies is reshaping clinical pathways, while procedural venue shifts and tariff-driven supply chain responses require nimble operational planning. Stakeholders that align evidence generation with real-world procedural needs, invest in clinician education, and build resilient manufacturing and distribution strategies will be best positioned to translate innovation into sustainable adoption and improved patient outcomes.

Looking ahead, the interplay between clinical utility, reimbursement design, and operational efficiency will determine which technologies achieve broad diffusion and which remain niche. Consequently, sustained collaboration among clinicians, manufacturers, and health system purchasers will be critical to ensuring that device innovation continues to deliver measurable clinical benefit and system-level value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms into CAD diagnostic imaging workflows
  • 5.2. Growing adoption of drug-eluting stents with biodegradable polymer coatings to reduce restenosis rates
  • 5.3. Emergence of minimally invasive percutaneous coronary intervention techniques guided by robotic assistance
  • 5.4. Rising investment in PCSK9 inhibitors and small interfering RNA therapies for LDL cholesterol management
  • 5.5. Expansion of telecardiology platforms for remote monitoring of patients with stable and acute CAD
  • 5.6. Development of bioresorbable scaffold technologies offering structural support without long-term vessel caging
  • 5.7. Increasing utilization of fractional flow reserve derived from CT angiography for noninvasive lesion assessment
  • 5.8. Advancements in wearable cardiac sensors for continuous monitoring and early detection of ischemic events
  • 5.9. Shift towards value-based care models prioritizing cost-effective CAD interventions and patient outcomes
  • 5.10. Collaborative clinical trials exploring gene therapy approaches for enhancing coronary vessel regeneration

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Coronary Artery Disease Market, by Product Type

  • 8.1. Balloon Catheters
  • 8.2. Coronary Stents
    • 8.2.1. Bare Metal Stents
    • 8.2.2. Bioresorbable Scaffolds
    • 8.2.3. Drug Eluting Stents
  • 8.3. Embolic Protection Devices
  • 8.4. Guidewires
  • 8.5. Imaging Systems
    • 8.5.1. Intravascular Ultrasound
    • 8.5.2. Optical Coherence Tomography

9. Coronary Artery Disease Market, by Procedure Type

  • 9.1. Coronary Artery Bypass Grafting
    • 9.1.1. Off Pump
    • 9.1.2. On Pump
  • 9.2. Percutaneous Coronary Intervention
    • 9.2.1. Balloon Angioplasty
    • 9.2.2. Stenting

10. Coronary Artery Disease Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Cardiology Clinics
  • 10.3. Hospitals

11. Coronary Artery Disease Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Coronary Artery Disease Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Coronary Artery Disease Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Abbott Laboratories
    • 14.3.2. Boston Scientific Corporation
    • 14.3.3. Medtronic plc
    • 14.3.4. Terumo Corporation
    • 14.3.5. B. Braun Melsungen AG
    • 14.3.6. Johnson & Johnson
    • 14.3.7. Becton Dickinson and Company
    • 14.3.8. Koninklijke Philips N.V.
    • 14.3.9. Edwards Lifesciences Corporation
    • 14.3.10. Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. CORONARY ARTERY DISEASE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. CORONARY ARTERY DISEASE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CORONARY ARTERY DISEASE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BALLOON CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BALLOON CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BALLOON CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BALLOON CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BARE METAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BARE METAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BARE METAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BARE METAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DRUG ELUTING STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DRUG ELUTING STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DRUG ELUTING STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DRUG ELUTING STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY GUIDEWIRES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY INTRAVASCULAR ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY OFF PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY OFF PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY OFF PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY OFF PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY OFF PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY OFF PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ON PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ON PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ON PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ON PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ON PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ON PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BALLOON ANGIOPLASTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BALLOON ANGIOPLASTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BALLOON ANGIOPLASTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BALLOON ANGIOPLASTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BALLOON ANGIOPLASTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BALLOON ANGIOPLASTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY STENTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY STENTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY STENTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY STENTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY STENTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY STENTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CARDIOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CARDIOLOGY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CARDIOLOGY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CARDIOLOGY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CARDIOLOGY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CARDIOLOGY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
  • TABLE 220. MIDDLE EAST CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. MIDDLE EAST CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2024 (USD MILLION)
  • TABLE 226. MIDDLE EAST CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
  • TABLE 236. AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2025-2032 (USD MILLION)
  • TABLE 237. AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 238. AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 239. AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2024 (USD MILLION)
  • TABLE 242. AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2025-2032 (USD MILLION)
  • TABLE 243. AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 244. AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2025-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2024 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2025-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. ASEAN CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
  • TABLE 270. ASEAN CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2025-2032 (USD MILLION)
  • TABLE 271. ASEAN CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 272. ASEAN CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 273. ASEAN CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. ASEAN CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. ASEAN CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2024 (USD MILLION)
  • TABLE 276. ASEAN CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. GCC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GCC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GCC CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. GCC CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. GCC CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
  • TABLE 286. GCC CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2025-2032 (USD MILLION)
  • TABLE 287. GCC CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 288. GCC CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 289. GCC CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. GCC CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. GCC CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2024 (USD MILLION)
  • TABLE 292. GCC CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2025-2032 (USD MILLION)
  • TABLE 293. GCC CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 294. GCC CORONARY ARTERY DISEASE MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 295. GCC CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. GCC CORONARY ARTERY DISEASE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPEAN UNION CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPEAN UNION CORONARY ARTERY DISEASE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPEAN UNION CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY STENTS, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPEAN UNION CORONARY ARTERY DISEASE MARKET SIZE, BY IMAGING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION CORONARY ARTERY DISEASE MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. E